Wolley Martin J, Stowasser Michael
Endocrine Hypertension Research Centre, Greenslopes and Princess Alexandra Hospitals, University of Queensland School of Medicine, Ipswich Road, Woolloongabba, Brisbane, 4102, Australia.
Department of Nephrology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Curr Hypertens Rep. 2016 Apr;18(5):36. doi: 10.1007/s11906-016-0641-x.
Treatment-resistant hypertension is an increasingly recognised problem and is markedly over-represented in patients with chronic kidney disease (CKD). Recent evidence has clarified the heightened risk for both adverse renal and cardiovascular outcomes associated with resistant hypertension, even when blood pressure control is attained. The diagnosis of resistant hypertension in CKD is reliant on accurate blood pressure measurement, and out of office measurements are important due to the high prevalence of masked hypertension in these patients. Treatment strategies include careful dietary measures to restrict sodium intake, and a focus on improving adherence to antihypertensive medications. Medication choices should focus on a sensible foundation and then diuretic titration to combat the salt and volume retention inherent in CKD. In this review, we discuss the epidemiology, pathogenesis and consequences of resistant hypertension in CKD, and then review the optimal diagnostic and management strategies.
难治性高血压是一个日益受到认可的问题,在慢性肾脏病(CKD)患者中显著多见。近期证据表明,即使血压得到控制,难治性高血压与不良肾脏和心血管结局的风险仍会增加。CKD患者难治性高血压的诊断依赖于准确的血压测量,由于这些患者中隐匿性高血压的患病率很高,诊室外测量很重要。治疗策略包括谨慎的饮食措施以限制钠摄入,并注重提高对抗高血压药物的依从性。药物选择应基于合理的基础,然后进行利尿剂滴定以对抗CKD固有的盐和容量潴留。在本综述中,我们讨论了CKD患者难治性高血压的流行病学、发病机制和后果,然后回顾了最佳诊断和管理策略。